These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Therapeutic induction of Helicobacter pylori bacteraemia in multiple sclerosis: how far from reality? Prasad H; Krishnaprasad MS; Karnaker VK Med Hypotheses; 2008 Oct; 71(4):610-1. PubMed ID: 18667280 [No Abstract] [Full Text] [Related]
43. Interferon-beta increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity. Krumbholz M; Faber H; Steinmeyer F; Hoffmann LA; Kümpfel T; Pellkofer H; Derfuss T; Ionescu C; Starck M; Hafner C; Hohlfeld R; Meinl E Brain; 2008 Jun; 131(Pt 6):1455-63. PubMed ID: 18474519 [TBL] [Abstract][Full Text] [Related]
44. [Therapy of multiple sclerosis]. Simó M Neuropsychopharmacol Hung; 2009 Mar; 11(1):23-6. PubMed ID: 19731815 [TBL] [Abstract][Full Text] [Related]
45. Genes and acute neurologic disease and injury: a primer for the neurologic intensive care nurse. Alexander SA; Beach M Crit Care Nurs Clin North Am; 2008 Jun; 20(2):203-12, vi. PubMed ID: 18424349 [TBL] [Abstract][Full Text] [Related]
51. Enhancement of chemokine expression by interferon beta therapy in patients with multiple sclerosis. Cepok S; Schreiber H; Hoffmann S; Zhou D; Neuhaus O; von Geldern G; Hochgesand S; Nessler S; Rothhammer V; Lang M; Hartung HP; Hemmer B Arch Neurol; 2009 Oct; 66(10):1216-23. PubMed ID: 19667211 [TBL] [Abstract][Full Text] [Related]
52. [Prognosis improves through early therapy from the beginning!]. Med Monatsschr Pharm; 2007 Oct; 30(10):381-2. PubMed ID: 17966289 [No Abstract] [Full Text] [Related]